L. Chovan (Bratislava, Slovakia), D. Bouros (Alexandroupolis, Greece)
Incentive spirometry has no advantage in preventing respiratory function decline after thoracic surgery
E. Zilber, A. Bogdanez (Petrozavodsk, Karelia, Russian Federation)
|   |
Comparison between clinic and home PEF monitoring
K. Tomita, Y. Hasegawa, M. Watanabe, A. Yamasaki, E. Shimizu, H. Sano, A. Touda (Yonago, Osaka, Japan)
| |
Airway and respiratory muscle function after spinal anesthesia
A. Bogdanez, O. Shishkin (Petrozavodsk, Karelia, Russian Federation)
| |
Differences in FEV1 do not discriminate differences in quality of life as differences in dyspnea does
R. J. Hernandez-Zenteno, A. Ramirez-Venegas, A. Velazquez M, R. H. Sansores M (Mexio City, Mexico City, Mexico)
| |
Lung function in children with inflammatory bowel diseases
J. Lange, K. Krenke, J. Peradzynska, A. Banaszkiewicz, P. Albrecht, M. Kulus, I. Lazowska, A. Radzikowski (Warsaw, Poland)
| |
FEV1/FEV3 ratio: a potential alternative to full spirometry for patients unable to sustain forced expiration?
N. Siddique, P. Yeung, M. Janczewski, S. Allen (Bournemouth, Poole, United Kingdom; Hong Kong, China)
| |
Exhaled and nasal NO levels in patients with primary cilliary dyskinesia (PCD)
J. Pawlik, W. Tomalak, W. Myszkal, J. Radlinski (Rabka, Poland)
| |
Evaluation of a method for respiratory muscle function testing
B. Gomez, M. Temprano, V. Bustamante, E. Lopez Santamaria, J. Galdiz (Baracaldo Vizcaya, Bilbao, Spain)
| |
The role of bronchial inhalation challenge in confirming professional bronchial sthma
N. Aranicki, S. Obradovic Andjelic, B. Zvezdin, N. Lalic, I. Kopitovic, Z. Dobric (Novi Sad, Serbia And Montenegro)
| |
Functional testing of the Omron MicroAir, a vibrating mesh nebulizer
K. Harris, G. Smaldone (Stony Brook, NY, United States Of America)
| |
The evaluation of pulmonary function tests and arterial blood gases among patients with amyotrophic lateral sclerosis
I. Hanta, S. Kuleci, F. Koc (Adana, Turkey)
| |
The lung function (LF) and quality of life (QL) at practically healthy persons (PHP) depending on the index of mass of body (IMB)
T. Konstantynovych, O. Nagornyak, M. Matsievych (Vinnitsa, Ukraine)
| |
Gastrointestinal reflux and pulmonary function – a pilot study
M. Tercelj, B. Salobir, K. Vukelic (Ljubljana, Grosuplje, Slovenia)
| |
Bronchyal hyperreactivity estimated by bronchodilatator test and FEF25-75/FVC ratio
S. Rancic, M. Rancic, J. Dukic (Nis, Serbia And Montenegro)
| |
²Nonobstructive² emphysema of the lung
A. G. Corsico, M. C. Zoia, R. Niniano, E. Gatto, G. Cervio, E. Ansaldo, A. Corsico, P. Cremaschi, E. Pozzi, I. Cerveri (Pavia, Italy)
| |
Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy
C. Belias, A. Pentheroudaki, G. Meletis, M. Chistodoulou, M. Ferdoutsis, G. Patsourakis, E. Thanou, C. Pigakis, E. Kirlaki, N. Kefalogiannis, N. Bachlitzanakis (Heraklion, Crete, Greece)
| |
Nebulisers or spacers to administer bronchodilators in emergency departments – a survey of current practice
N. Mason, N. Roberts, N. Yard, M. R. Partridge (London, United Kingdom)
| |
Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program
A. R. Koczulla, R. Bals, V. Kottke, K. H. Blackert, C. Vogelmeier (Marburg, Werne, Germany)
| |